Dr Stephen Richard Schwab, MD - Medicare Emergency Medicine in Greenwood, SC

Dr Stephen Richard Schwab, MD is a medicare enrolled "Emergency Medicine" physician in Greenwood, South Carolina. His current practice location is 1325 Spring St, Greenwood, South Carolina. You can reach out to his office (for appointments etc.) via phone at (864) 725-4780.

Dr Stephen Richard Schwab is licensed to practice in South Carolina (license number 18514) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1770681876.

Contact Information

Dr Stephen Richard Schwab, MD
1325 Spring St,
Greenwood, SC 29646
(864) 725-4780
(864) 725-7448



Physician's Profile

Full NameDr Stephen Richard Schwab
GenderMale
SpecialityEmergency Medicine
Location1325 Spring St, Greenwood, South Carolina
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1770681876
  • Provider Enumeration Date: 09/20/2006
  • Last Update Date: 08/16/2018
  Medicare PECOS Information:
  • PECOS PAC ID: 1052347945
  • Enrollment ID: I20051214000620

Medical Identifiers

Medical identifiers for Dr Stephen Richard Schwab such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1770681876NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207P00000XEmergency Medicine 18514 (South Carolina)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Stephen Richard Schwab allows following entities to bill medicare on his behalf.
Entity NamePrisma Health University Medical Group
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1295763217
PECOS PAC ID: 8325950983
Enrollment ID: O20031103000238

News Archive

Phase II clinical study to evaluate Nanocort commenced

Galapagos NV announced today that it has started a Phase II clinical study to evaluate Nanocort's effectiveness in treating flares in multiple sclerosis (MS). Nanocort combines less frequent treatment with lower dosage and potentially more effective delivery than other MS flare treatments.

Will the future of global health rely upon addressing air pollution?

We speak to Dr. Philip Landrigan about his latest research into air pollution and how African countries are in a prime position to take action against it.

Mazor Robotics third quarter revenue increases 171% to $4.2/16.2 million NIS

Mazor Robotics Ltd., a developer of innovative surgical robots and complementary products, today filed its financial statements with the Tel Aviv Stock Exchange for the third quarter ended September 30, 2012.

Teva concludes Asset Transfer Agreement with NeuroSearch

Teva Pharmaceutical Industries Ltd announced today that it has concluded an Asset Transfer Agreement with NeuroSearch A/S of Denmark to purchase all rights, assets and obligations relating to Huntexil (pridopidine / ACR16), a drug candidate being developed for the symptomatic treatment of hand movement, balance and gait disturbances in Huntington disease (HD).

Read more Medical News

› Verified 8 days ago

Entity NameBaptist Easley Hospital
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1144452889
PECOS PAC ID: 0840337606
Enrollment ID: O20091027000684

News Archive

Phase II clinical study to evaluate Nanocort commenced

Galapagos NV announced today that it has started a Phase II clinical study to evaluate Nanocort's effectiveness in treating flares in multiple sclerosis (MS). Nanocort combines less frequent treatment with lower dosage and potentially more effective delivery than other MS flare treatments.

Will the future of global health rely upon addressing air pollution?

We speak to Dr. Philip Landrigan about his latest research into air pollution and how African countries are in a prime position to take action against it.

Mazor Robotics third quarter revenue increases 171% to $4.2/16.2 million NIS

Mazor Robotics Ltd., a developer of innovative surgical robots and complementary products, today filed its financial statements with the Tel Aviv Stock Exchange for the third quarter ended September 30, 2012.

Teva concludes Asset Transfer Agreement with NeuroSearch

Teva Pharmaceutical Industries Ltd announced today that it has concluded an Asset Transfer Agreement with NeuroSearch A/S of Denmark to purchase all rights, assets and obligations relating to Huntexil (pridopidine / ACR16), a drug candidate being developed for the symptomatic treatment of hand movement, balance and gait disturbances in Huntington disease (HD).

Read more Medical News

› Verified 8 days ago

Entity NamePrisma Health-upstate
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1649726738
PECOS PAC ID: 5698063162
Enrollment ID: O20161222000767

News Archive

Phase II clinical study to evaluate Nanocort commenced

Galapagos NV announced today that it has started a Phase II clinical study to evaluate Nanocort's effectiveness in treating flares in multiple sclerosis (MS). Nanocort combines less frequent treatment with lower dosage and potentially more effective delivery than other MS flare treatments.

Will the future of global health rely upon addressing air pollution?

We speak to Dr. Philip Landrigan about his latest research into air pollution and how African countries are in a prime position to take action against it.

Mazor Robotics third quarter revenue increases 171% to $4.2/16.2 million NIS

Mazor Robotics Ltd., a developer of innovative surgical robots and complementary products, today filed its financial statements with the Tel Aviv Stock Exchange for the third quarter ended September 30, 2012.

Teva concludes Asset Transfer Agreement with NeuroSearch

Teva Pharmaceutical Industries Ltd announced today that it has concluded an Asset Transfer Agreement with NeuroSearch A/S of Denmark to purchase all rights, assets and obligations relating to Huntexil (pridopidine / ACR16), a drug candidate being developed for the symptomatic treatment of hand movement, balance and gait disturbances in Huntington disease (HD).

Read more Medical News

› Verified 8 days ago

Entity NameIch Er Services Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1174002059
PECOS PAC ID: 2860744331
Enrollment ID: O20181010003402

News Archive

Phase II clinical study to evaluate Nanocort commenced

Galapagos NV announced today that it has started a Phase II clinical study to evaluate Nanocort's effectiveness in treating flares in multiple sclerosis (MS). Nanocort combines less frequent treatment with lower dosage and potentially more effective delivery than other MS flare treatments.

Will the future of global health rely upon addressing air pollution?

We speak to Dr. Philip Landrigan about his latest research into air pollution and how African countries are in a prime position to take action against it.

Mazor Robotics third quarter revenue increases 171% to $4.2/16.2 million NIS

Mazor Robotics Ltd., a developer of innovative surgical robots and complementary products, today filed its financial statements with the Tel Aviv Stock Exchange for the third quarter ended September 30, 2012.

Teva concludes Asset Transfer Agreement with NeuroSearch

Teva Pharmaceutical Industries Ltd announced today that it has concluded an Asset Transfer Agreement with NeuroSearch A/S of Denmark to purchase all rights, assets and obligations relating to Huntexil (pridopidine / ACR16), a drug candidate being developed for the symptomatic treatment of hand movement, balance and gait disturbances in Huntington disease (HD).

Read more Medical News

› Verified 8 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Stephen Richard Schwab is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Stephen Richard Schwab, MD
1 Independence Pt, Suite 212,
Greenville, SC 29615-4545

Ph: (864) 797-6307
Dr Stephen Richard Schwab, MD
1325 Spring St,
Greenwood, SC 29646

Ph: (864) 725-4780

News Archive

Phase II clinical study to evaluate Nanocort commenced

Galapagos NV announced today that it has started a Phase II clinical study to evaluate Nanocort's effectiveness in treating flares in multiple sclerosis (MS). Nanocort combines less frequent treatment with lower dosage and potentially more effective delivery than other MS flare treatments.

Will the future of global health rely upon addressing air pollution?

We speak to Dr. Philip Landrigan about his latest research into air pollution and how African countries are in a prime position to take action against it.

Mazor Robotics third quarter revenue increases 171% to $4.2/16.2 million NIS

Mazor Robotics Ltd., a developer of innovative surgical robots and complementary products, today filed its financial statements with the Tel Aviv Stock Exchange for the third quarter ended September 30, 2012.

Teva concludes Asset Transfer Agreement with NeuroSearch

Teva Pharmaceutical Industries Ltd announced today that it has concluded an Asset Transfer Agreement with NeuroSearch A/S of Denmark to purchase all rights, assets and obligations relating to Huntexil (pridopidine / ACR16), a drug candidate being developed for the symptomatic treatment of hand movement, balance and gait disturbances in Huntington disease (HD).

Read more News

› Verified 8 days ago


Emergency Medicine Doctors in Greenwood, SC

Dr. Donald Jerome Maddox, M.D.
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 1325 Spring St, Greenwood, SC 29646
Phone: 864-725-4799    Fax: 864-725-4707
John G Robinson, MD
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1325 Spring St, Greenwood, SC 29646
Phone: 864-725-4780    Fax: 864-725-4778
Richard D Brooksbank, MD
Emergency Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 1325 Spring St, Greenwood, SC 29646
Phone: 864-725-4780    Fax: 864-725-4778
Gregory C Givens, M.D.
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1325 Spring St, Greenwood, SC 29646
Phone: 864-725-4780    Fax: 864-725-4778
John P Short, DO
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1325 Spring St, Greenwood, SC 29646
Phone: 864-725-4780    Fax: 864-725-4778
Dr. Michelle Maria Curry, M.D.
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1325 Spring St, Lakelands Emergency Physicians, Pa, Greenwood, SC 29646
Phone: 864-725-4799    Fax: 864-725-4707
Dr. Scot Heath Jones, M.D.
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1325 Spring St, Greenwood, SC 29646
Phone: 864-725-4780    Fax: 864-725-4778

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.